British researchers have demonstrated that a single, targeted dose of radiation in treating breast cancer can be just as effective as the prolonged course of radiotherapy that is commonly used to treat the disease.
A new vaccine called Provenge has just been accepted by the FDA, making it the first to be approved by the agency for men fighting advanced prostate cancer. While Provenge is not a cure, it has shown promise in extending the lives of patients.